UBS Group began coverage on shares of Exponent ( NASDAQ:EXPO – Get Rating ) in a research note issued to investors on Wednesday morning, The Fly reports. The firm issued a neutral rating and a $99.00 price objective on the business services provider's stock. Several other equities research analysts have also recently issued reports on the stock. StockNews.com began coverage on shares of Exponent in a research report on Thursday, May 18th. They set a hold rating for the company. TheStreet downgraded shares of Exponent from a b rating to a c+ rating in a report on Wednesday, May 17th.

https://www.dailypolitical.com/2023/06/04/exponent-nasdaqexpo-receives-new-coverage-from-analysts-at-ubs-group.html

#dailypolitical